Clinical trials: Motor Skills Development

Asperger's Syndrome, Dyslexia

My Scrivener® - Measuring Effectiveness and Dose Response in Children

• Completed
• Age: 5 to 19 years
• Phase 1/2
• Medical device

This study will assess whether a computer haptic peripheral device programmed to provide repetitive motion training is as effective as the same repetitive motion training provided by a human being.

Conditions

Asperger's Syndrome, Dyslexia, Cerebral Palsy, Attention Deficit Disorder

Trial name

NCT00919906

Testing

My Scrivener(R)

Where

United States

Volunteers

176 people

Sponsor

Obslap Research LLC